Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmaniaga Lifescience is a premier pharmaceutical manufacturing entity based in Malaysia and a core subsidiary of Pharmaniaga Berhad. The company operates state-of-the-art facilities that are EU-GMP certified, focusing on the production of a wide array of generic medicines including oral solids, liquids, and topicals. It gained significant international recognition for its rapid implementation of a fill-and-finish facility for the Sinovac COVID-19 vaccine, bolstering regional vaccine security. Beyond vaccines, the company provides comprehensive contract manufacturing and development services (CDMO) to global partners. Its strategic focus remains on expanding its portfolio in high-value therapeutic areas such as cardiovascular, central nervous system, and anti-infectives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pharmaniaga Lifescience.